Application Note Biologics & Biosimilars Fraction Analysis of Cysteine‑Linked Antibody-Drug Conjugates Using Hydrophobic Interaction Chromatography Agilent 1260 Infinity II Bio-Inert System mAU 700 600 500 400 300 200 100 0 5.0 Author Sonja Schneider Agilent Technologies, Inc Waldbronn, Germany 7.5…
Key words
fraction, hic, brentuximab, mau, vedotin, collection, fractionation, collector, fractions, min, hydrophobic, antibody, conjugates, cysteine, drug